|English to Chinese: Using biosensor-based Biacore assays to meet current analytical challenges in vaccine development|
General field: Medical
|Source text - English|
What are the challenges facing the vaccine industry today?
We are facing a paradoxical situation today -
vaccines are by far the most effective healthcare
intervention available to any country in the world.
In spite of this the level of profitability of vaccine
companies has been very low and the vaccine
industry was not attractive to investors.
The recent occurrence of global health threats like
SARS (severe acute respiratory syndrome) and
avian flu (caused by H5N1 influenza virus) has had a
beneficial effect since it has changed the perception
of the US government and the general population to
the risks and implications of possible future worldwide
pandemics. National vaccine budgets have been
increased substantially during the last two years
and a number of private initiatives have injected
considerable sums of money in vaccine development.
Another positive development is the decision made
by several countries to stockpile vaccine supplies
purchased at a price that will encourage companies
to undertake vaccine development.
One result of this renewed interest is that outdated
technologies, such as the production of influenza
vaccine in embryonated eggs, will soon be replaced
by modern fermentation processes that allow much
faster vaccine production.
|Translation - Chinese|